Local Triggering of the ICOS Coreceptor by CD11c+ Myeloid Cells Drives Organ Inflammation in Lupus  by Teichmann, Lino L. et al.
ArticleLocal Triggering of the ICOS Coreceptor by CD11c+
Myeloid Cells Drives Organ Inflammation in LupusHighlightsd ICOSL deficiency in CD11c+ myeloid cells attenuates organ
inflammation in lupus
d Autoantibody production is largely unaffected by the loss of
ICOSL in CD11c+ cells
d CD11c+ cells through ICOSL locally protect organ-infiltrating
T cells from apoptosis
d ICOSL display by CD11c+ myeloid cells promotes PI3K-Akt
signaling in invading T cellsTeichmann et al., 2015, Immunity 42, 552–565
March 17, 2015 ª2015 Elsevier Inc.
http://dx.doi.org/10.1016/j.immuni.2015.02.015Authors
Lino L. Teichmann, Jaime L. Cullen, ...,
Joe Craft, Mark J. Shlomchik
Correspondence
lino.teichmann@uni-bonn.de
In Brief
How the inducible T cell costimulator
(ICOS) promotes organ inflammation in
lupus is unclear. Shlomchik and
colleagues demonstrate that in inflamed
kidneys infiltrating T cells require ICOS
stimulation by local CD11c+ myeloid cells
for their survival, an effect mediated by
PI3K-Akt signaling.
Immunity
Article
Local Triggering of the ICOS Coreceptor by CD11c+
Myeloid Cells Drives Organ Inflammation in Lupus
Lino L. Teichmann,1,* Jaime L. Cullen,2 Michael Kashgarian,3 Chen Dong,6 Joe Craft,2,4 and Mark J. Shlomchik2,5,7
1Department of Medicine III, University of Bonn School of Medicine, 53127 Bonn, Germany
2Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06519, USA
3Department of Pathology, Yale University School of Medicine, New Haven, CT 06519, USA
4Department of Internal Medicine Section of Rheumatology, Yale University School of Medicine, New Haven, CT 06519, USA
5Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT 06519, USA
6Institute for Immunology, Tsinghua University, Beijing, 100084, China
7Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA
*Correspondence: lino.teichmann@uni-bonn.de
http://dx.doi.org/10.1016/j.immuni.2015.02.015
SUMMARY
The inducible T cell costimulator (ICOS) is a potent
promoter of organ inflammation in murine lupus.
ICOS stimulates T follicular helper cell differentiation
in lymphoid tissue, suggesting that it might drive
autoimmunity by enhancing autoantibody produc-
tion. Yet the pathogenic relevance of this mechanism
remains unclear. It is also unknown whether other
ICOS-induced processes might contribute to lupus
pathology. Here we show that selective ablation of
ICOS ligand (ICOSL) in CD11c+ cells, but not in B
cells, dramatically ameliorates kidney and lung
inflammation in lupus-prone MRL.Faslpr mice. Auto-
antibody formation was largely unaffected by ICOSL
deficiency in CD11c+ cells. However, ICOSL display
by CD11c+ cells in inflamed organs had a nonre-
dundant role in protecting invading T cells from
apoptosis by elevating activity of the PI3K-Akt sig-
naling pathway, thereby facilitating T cell accrual.
These findings reveal a mechanism that locally sus-
tains organ inflammation in lupus.
INTRODUCTION
Systemic lupus erythematosus (SLE) is a relapsing-remitting
autoimmune syndrome in which aberrant T cell function leads
to multi-organ inflammation (Bagavant and Fu, 2009). This path-
ological T cell response is orchestrated by various antigen-pre-
senting cell (APC) subsets. Previous studies have demonstrated
that B cells are critical for the induction of T cell autoimmunity in
lupus mouse models (Chan and Shlomchik, 1998; Jacob et al.,
2011). This function of B cells is partly dependent on their prior
activation via the MyD88 pathway (Teichmann et al., 2013). In
contrast, we recently demonstrated that CD11c+ cells, such as
dendritic cells (DCs) and certain macrophages, contribute to
T cell pathogenicity after disease is initiated, leading to tissue
damage (Teichmann et al., 2010). Defining the signals by which
specific types of APCs drive T cell autoimmunity and elucidating
where and when these signals play a role will advance our
capacity to develop new therapeutics that rely on disrupting
T cell-APC interactions.
Accumulating evidence suggests that the T cell-expressed
inducible costimulator (ICOS) is instrumental in T cell-driven
multi-organ inflammation in lupus. In MRL.Faslpr mice, a mouse
model of spontaneous systemic autoimmunity that is based on
polygenic factors in the MRL genetic background and acceler-
ated by Fas-deficiency, deletion of Icos confers protection
from proteinuria and interstitial nephritis (Odegard et al.,
2009). In sanroque mice, a single amino acid substitution in
Roquin-1 precipitates a lupus-like disease that is thought to
arise from deregulated expression of multiple genes in the im-
mune system, including Icos (Leppek et al., 2013). ICOSL (B7h,
B7RP-1), the only known ligand for ICOS, is expressed by B
cells, conventional DCs (cDCs), macrophages, and non-he-
matopoietic cells. Notably, ICOSL is expressed by renal tubu-
loepithelial cells (de Haij et al., 2005), which might play a role
in nephritis.
Upon ligation ICOS signals through PI3K. It contains a
unique YMFM SH2 binding motif that has the ability to recruit
a PI3K variant composed of the canonical p110 catalytic sub-
unit and the p50a regulatory subunit (Fos et al., 2008). This
form of PI3K has a particularly high lipid kinase activity. Its
activation thus leads to robust production of phosphatidylino-
sitol (3,4,5)-trisphosphate (PIP3) and concomitant stimulation
of Akt kinase and mammalian target of rapamycin (mTOR).
The PI3K-Akt pathway promotes cell proliferation and sur-
vival. Commensurately, in adoptive transfer studies, expan-
sion and survival of effector OT-II CD4+ T cells deficient for
ICOS was impaired, although it was not demonstrated
whether this was due to reduced Akt activity (Burmeister
et al., 2008).
ICOS signals are required for T follicular helper cell (Tfh)
development. Tfh cells are a specialized subset of CD4+
T cells that localize to germinal centers and stimulate survival,
proliferation, selection, and differentiation of germinal center
B cells. The transcriptional repressor Bcl6 is the defining tran-
scription factor of Tfh cells. A sequential model was proposed
in which Bcl6 expression is induced by ICOS-mediated signals
during CD4+ T cell priming by DCs (Choi et al., 2011). After
migration of T cells to the T:B border its sustained expression
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relies on ICOS ligation by cognate B cells, although this re-
quirement can be overcome by high doses of antigen (Ag)
(Weinstein et al., 2014). Recruitment of T cells from the T:B
border into follicles appears to be facilitated by ICOSL on
non-cognate B cells in a Bcl6-independent manner (Xu et al.,
2013). c-Maf, a transcription factor that drives secretion of
the Tfh cell signature cytokine interleukin-21 (IL-21), is also
induced by ICOS (Bauquet et al., 2009).
Although these studies partially delineated the functions of
ICOS in T cell responses to immunizations and infections, there
remains a paucity of information regarding the mechanistic
underpinning of ICOS-driven systemic autoimmunity. It is un-
known which cell types are primarily responsible for promoting
lupus by engaging ICOS. Whether ICOS has non-redundant
functions in inhibiting apoptosis and cell cycle arrest in lupus
has not been shown. Conceivably, the ubiquity of (self-) Ag
and the inflammatory milieu obviates the need for ICOS-
induced activation of the PI3K-Akt pathway. In several mouse
models of SLE, including MRL.Faslpr mice, differentiation of B
cells into autoantibody (auto-Ab)-secreting cells takes place
extrafollicularly. In these mice, auto-Ab generation is thought
to be supported by CD4+ T cells in the red pulp that resemble
Tfh cells in gene-expression profile and B cell helper function-
ality (Odegard et al., 2008). Those cells are called T extrafollic-
ular helper cells (Tefh). Like Tfh cells, they express Bcl6 and
secrete IL-21. Deletion of Icos in MRL.Faslpr mice reduces the
frequency of Tefh cells (Odegard et al., 2008), but it is unclear
whether this is due to a lack of Bcl6 expression. If so, it is ques-
tionable whether Bcl6 is initially induced by DCs given that in
this strain T cell activation is largely independent of DCs (Teich-
mann et al., 2010) but highly dependent on B cells (Chan and
Shlomchik, 1998). Finally, a recent study described Bcl6+IL-
21+ T helper (Th) cells in the pancreas and salivary glands of
NOD mice, a murine model of type I diabetes, that facilitated
CD8+ T cell expansion and b-islet destruction (McGuire et al.,
2011). Thus, the critical function of Bcl6+ Th cells in lupus might
not only be to help B cells and promote auto-Ab production but
rather to assist cytotoxic T cells or to directly promote tissue
damage.
To begin to address these issues, we used a tissue-specific
gene deletion approach in a fully backcrossed lupus-prone
mouse strain. Specifically, we undertook a comprehensive
analysis of MRL.Faslpr mice deficient for Icosl either in B cells
or CD11c+ cells, which include DCs and CD11c+ macrophages.
Our results uncover that mechanistic insights into ICOS-depen-
dent T cell immunity gained from immunization or infection
studies are of limited applicability to chronic systemic autoimmu-
nity and provide a framework for understanding the effects of
ICOS-targeted therapies that are currently being investigated.
RESULTS
ICOS Triggering by CD11c+ Cells Promotes Interstitial
Nephritis and Pneumonia
To investigate the contribution of ICOS ligation by CD11c+ cells
and B cells to lupus development, we crossed Icosllfl/fl
MRL.Faslpr mice to Itgax-Cre and CD19-Cre MRL.Faslpr lines,
respectively. In Itgax-Cre Icoslfl/fl MRL.Faslpr mice (referred to
as Itgax-IcoslD hereafter) 95.2% of Icoslfl alleles in splenic
cDCs were deleted (Table S1) as determined by qRT-PCR on
genomic DNA. Icoslfl ablation in red pulp macrophages was
minimal (Table S1) but Itgax-Cre is active in peripheral tissue
macrophages that express CD11c. Accordingly, 91.2% of
Icoslfl alleles in the CD11c+MHCII+ cell subset in kidneys,
which contains cDCs and macrophages (Satpathy et al.,
2012), from Itgax-IcoslD mice were excised. In Cd19-Cre
Icosllfl/fl MRL.Faslpr mice (Cd19-IcoslD) ablation of Icoslfl in B
cells was very effective (95.8%, Table S1). The extent of Icoslfl
deletion in Ab-forming cells (90.3%, Table S1) was comparable
to that in B cells, suggesting that there was no selection for B
cells that retained Icosl alleles during activation or differentia-
tion. These data demonstrate that the Cre-loxP system is well
suited to decipher the consequences of ICOS engagement by
CD11c+ cells and B cells in lupus.
Multiorgan inflammation in MRL.Faslpr mice is dependent on
both CD11c+ and B cells (Chan et al., 1999; Teichmann et al.,
2010). To test whether ICOS triggering by these cell types pro-
motes immune infiltration of tissues, we performed a thorough
analysis of several lupus target organs in Itgax-IcoslD and
Cd19-IcoslD mice. Proteinuria, a measure of kidney function,
was strikingly reduced in Itgax-IcoslD mice compared to con-
trols (Figure 1A). Histopathological evaluation of kidneys using
a semiquantitative scoring system revealed that the decrease
in proteinuria was associated with markedly less interstitial
nephritis (IN, Figure 1B) whereas glomerulonephritis (GN, Fig-
ure 1B) was unaltered. There was a 59.0% reduction in relative
infiltrate size in mice lacking ICOSL on CD11c+ cells (Figures
1C and 1F), quantitatively confirming the IN scoring. Unlike in
Itgax-IcoslD mice, renal disease in Cd19-IcoslD mice was unaf-
fected (Figures 1D and 1E). A similar examination of lungs
further revealed a substantial reduction in lung inflammation
in the absence of ICOSL on CD11c+ cells (Figures 1H–1J).
Finally, we assessed whether Icosl deletion in CD11c+ or B
cells would affect the skin. Because skin inflammation is
more common in MRL.Faslpr females than in males, we limited
our analysis to females. Surprisingly, Icosl ablation in CD11c+
cells did not protect from dermatitis (Figure 1G). Similarly,
dermatitis severity in Cd19-IcoslD mice and controls was indis-
tinguishable (Figure 1G). Taken together, ICOS ligation by
CD11c+ cells drives IN and interstitial pneumonia, but does
not contribute to dermatitis development indicating separate
pathogenetic mechanisms.
ICOSL-Deficiency in CD11c+ Cells Causes a Loss of
Splenic Tefh and Effector CD8+ T Cells in Lupus
In previous work, we have shown that T cell activation relies on B
cells but not CD11c+ cells, whereas T cell expansion and differ-
entiation into IFN-g producing effectors is mediated by both cell
types in theMRL.Faslpr strain (Chan and Shlomchik, 1998; Teich-
mann et al., 2010; Teichmann et al., 2013). We sought to clarify
how ICOS triggering by distinct APCs impacts the spontaneous
T cell response. Aged MRL.Faslpr mice develop splenomegaly
and lymphadenopathy resulting from the accumulation of
T cells, especially a subset characteristic of Fas-deficient mice
that does not express the coreceptors CD4 and CD8. Spleen
weight in Itgax-IcoslD and Cd19-IcoslD mice was similar to that
in their respective controls (Figure 2A). Accordingly, the loss of
ICOSL on CD11c+ or B cells did not affect splenic CD4+, CD8+
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Figure 1. ICOS Triggering by CD11c+ Cells Promotes Interstitial Nephritis and Pneumonia
(A) Proteinuria scores of control and Itgax-IcoslD mice.
(B) Glomerular nephritis was scored from 0 to 6 and and interstitial nephritis from 0 to 3. Shown are scores of control and Itgax-IcoslD mice.
(C) The area of renal interstitial infiltrates expressed as a percentage of the total kidney section area of control (n = 25) and Itgax-IcoslD (n = 13) mice.
(D and E) As in (A) and (B) but for control and Cd19-IcoslD mice.
(F) Representative low magnification images of H&E stained kidneys sections (scale bar represents 2 mm) illustrating perivascular infiltrates in kidneys from
control and Itgax-IcoslD mice.
(G) Dermatitis scores of control and Itgax-IcoslD mice (left graph), or control and Cd19-IcoslD mice (right graph).
(legend continued on next page)
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or CD4CD8 T cell numbers (Figure 2B). Thus, T cell accumu-
lation was not substantially impaired in the absence of ICOSL
on CD11c+ or B cells.
Tfh cells have been the focus of intense research, but little
is known about their Tefh counterparts. To test whether Tefh
cells require CD11c+ or B cells, we determined the frequency
of Tefh cells among CD4+ T cells in MRL.Faslpr mice that consti-
tutively lack B cells (Jh MRL.Faslpr) or most CD11c+ cells (Itgax-
Cre Rosa26-eGFP-DTA MRL.Faslpr, referred to as Itgax-DTA;
Teichmann et al., 2010). Tefh cells were identified based on
the surface phenotype PSGL-1loCD44+CD62LTCRb+CD45R.
Corresponding to their extrafollicular position, Tefh cells do not
(H) Interstitial pneumonia was scored from 0 to 6 for control and Itgax-IcoslD mice.
(I) The pulmonary infiltrate area expressed as a percentage of the total lung section area of control (n = 11) and Itgax-IcoslD (n = 11) mice.
(J) Representative low magnification images of H&E stained lung sections (scale bar represents 2 mm) illustrating pulmonary infiltrates in control and Itgax-IcoslD
mice.
In scatter plots each dot represents an individual mouse and horizontal lines represent the median. Data in bar graphs are represented as mean ± SEM. See also
Table S1.
Figure 2. ICOSL-Deficiency in CD11c+ Cells Causes a Selective Loss of Tefh Cells, CD8+ Teff and Tem Cells in Spleens of Lupus-Prone Mice
(A) Spleen weight of control (n = 34) and Itgax-IcoslD (n = 23) mice, or control (n = 32) and Cd19-IcoslD (n = 21) mice.
(B) Numbers of T cells per spleen of control (n = 25) and Itgax-IcoslD (n = 13) mice, or control (n = 25) and Cd19-IcoslD (n = 11) mice.
(C) Frequency of Tefh cells among CD4+ T cells in spleens from Itgax-IcoslD, Cd19-IcoslD, Itgax-DTA, and Jh MRL.Faslpr mice with their respective controls.
Contour plots illustrate the last gating step for Tefh cells (TCRb+CD45RCD4+CD44+CD62LPSGL-1lo) (values indicate percentage of CD4+ T cells, mean). n = 13
for Itgax-IcoslDmice and n = 25 for controls; n = 20 for Cd19-IcoslDmice and n = 29 for controls; n = 9 Itgax-DTA and n = 12 for controls; n = 16 for JhMRL.Faslpr
mice and n = 12 for controls.
(D) Frequency of Teff and Tem cells among CD8+ T cells in spleens from Itgax-IcoslD and Cd19-IcoslDmice with their respective controls. Contour plots illustrate
the last two gating steps for Tem (TCRb+CD45RCD8+CD44+CD62LCD127+) and Teff (as Tem but CD127) cells (values indicate percentage of CD8+ T cells,
mean). n = 15 for Itgax-IcoslD mice and n = 13 for controls; n = 10 for Cd19-IcoslD mice and n = 12 for controls.
Data in bar graphs are represented as mean ± SEM. See also Figure S1.
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express CXCR5. Both B and CD11c+ cells contribute to Tefh
development, as the CD4+ T cell pool contained considerably
fewer Tefh cells in both B cell-deficient (Jh MRL.Faslpr, 69%)
and CD11c+ cell-deficient (Itgax-DTA, 44%) mice (Figure 2C).
Tfh cells need ICOSL first on DCs for phenotype induction and
then on B cells for maintenance. We therefore investigated
Tefh cell frequencies in Itgax-IcoslD and Cd19-IcoslD mice. The
loss of ICOSL on CD11c+ cells resulted in a 28% decrease
in Tefh cells among CD4+ T cells (Figure 2C) while the propor-
tion of CD4+ T cells that were PSGL-1hi (PSGL-1hiCD44+
CD62LTCRb+CD45R) remained unchanged (Figure S1A). B
cell-specific ICOSL-deficiency caused only a slight decrement
in Tefh cells (Figure 2C) and did not affect PSGL-1hi CD4+
T cells (Figure S1A). Because the Tfh cell differentiation pathway
is co-opted by natural T regulatory (Treg) cells we studied FoxP3
expression by Tefh cells. Interestingly, a subset of Tefh cells in
MRL.Faslpr mice expressed FoxP3 (Figure S1B); however, the
relative abundance of FoxP3+ Tefh cells was unchanged in
Itgax-DTA, Itgax-IcoslD, andCd19-IcoslDmice compared to their
littermate controls. Only Jh MRL.Faslpr mice showed a small
Figure 3. Expression of the Tefh Cell Gene
Program Does Not Require ICOSL on
CD11c+ or B Cells
(A) Mean fluorescence intensity (MFI) for Bcl6 (y
axis) and CXCR4 (expression of which is directly
regulated by Bcl6, x axis) of Tefh cells in spleens
from Itgax-DTA, Jh MRL.Faslpr, Itgax-IcoslD, and
Cd19-IcoslD mice with their respective controls.
n = 6 for Itgax-IcoslD mice and n = 6 for
controls; n = 10 for Cd19-IcoslD mice and n = 23
for controls; n = 7 Itgax-DTA and n = 6 for
controls; n = 4 for JhMRL.Faslprmice and n = 8 for
controls.
(B) Flow cytometry plots show intracellular IL-21
and IFN-g staining of gated Tefh cells of PMA-
ionomycin stimulated splenocytes from Itgax-
DTA, Jh MRL.Faslpr, Itgax-IcoslD and Cd19-IcoslD
micewith their respective controls. Values indicate
percentage of Tefh cells (mean). n = 17 for Itgax-
IcoslDmice and n = 17 for controls; n = 8 for Cd19-
IcoslDmice and n = 12 for controls; n = 6 Itgax-DTA
and n = 10 for controls; n = 11 for Jh MRL.Faslpr
mice and n = 8 for controls.
See also Figure S2.
reduction in FoxP3+ Tefh cells. Together,
FoxP3 Tefh cells rely on ICOS engage-
ment by CD11c+ cells and, to a minor
extent, by B cells.
It has been suggested that ICOS sig-
nals augment CD8+ T cell immunity
(Wallin et al., 2001). To explore ICOS-
mediated effects on CD8+ T cells in lupus,
we measured the frequencies of CD8+
T cells with a terminal-effector (Teff,
CD44+CD62LCD127) and effector-
memory (Tem, CD44+CD62LCD127+)
phenotype in spleens from Itgax-IcoslD
and Cd19-IcoslD mice. ICOSL-deficiency
in CD11c+ cells led to a marked reduction
of both subsets, whereas a lack of ICOSL on B cells had no
discernible effect (Figure 2D).
We conclude that in the context of chronic systemic autoim-
munity the ablation of Icosl in CD11c+ cells leads to a partial
loss of FoxP3- Tefh cells, and CD8+ Teff and Tem cells in the
spleen without affecting overall T cell numbers.
Deletion of Icosl in CD11c+ or B Cells Does Not Block the
Tefh Cell Program
Although cells with a Tefh phenotype were to varying degree
reduced in Itgax-DTA, Jh MRL.Faslpr, Itgax-IcoslD, and Cd19-
IcoslDmice, it remained unclear whether this was due to a failure
in Bcl6 expression. Residual Tefh cells in MRL.Faslpr mice lack-
ing CD11c+ or B cells displayed lower protein expression of Bcl6
than those in littermate controls, indicating that either the induc-
tion or sustained expression of Bcl6 was impaired (Figures 3A
and S2). Accordingly, surface expression of the chemokine re-
ceptor CXCR4, which is directly regulated by Bcl6, was dimin-
ished on Tefh cells from Itgax-DTA and JhMRL.Faslpr mice (Fig-
ures 3A and S2). In contrast, the loss of ICOSL on CD11c+ or B
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cells had no effect on Bcl6 or CXCR4 expression by Tefh cells in
Itgax-IcoslD and Cd19-IcoslD mice (Figure 3A and S2). Next, we
tested Tefh cell function by intracellular staining for IL-21 and
interferon-g (IFN-g) after restimulation with phorbol myristate ac-
etate (PMA) and ionomycin. IL-21 secretion, a key feature of Tefh
cells, is induced by the transcription factor c-Maf (Bauquet et al.,
2009). The substantial majority of Tefh cells that produced IL-21
also stained positive for IFN-g in control mice (Figure 3B).
Notably, the frequency IL-21+IFN-g+ cells among Tefh cells in
Itgax-DTA and Jh MRL.Faslpr mice was greatly reduced (Fig-
ure 3B). Deficiency for ICOSL in CD11c+ or B cells, however,
did not impair IL-21 and IFN-g production. In summary, Bcl-6
and IL-21 expression depend on both CD11c+ and B cells in
lupus, but not ICOS triggering by either cell type.
Auto-Ab Formation Is Largely Unimpaired in Mice
Deficient for ICOSL on B Cells or CD11c+ Cells
It has been proposed that Tfh cells enhance the production of
auto-Abs, the deposition of which in tissues triggers immune infil-
tration (Linterman et al., 2009). Conceivably, organ inflammation
in Itgax-IcoslD mice was therefore diminished because the
decrease in Tefhs cells restricted auto-Ab formation. The drop
in Tefh cells in Cd19-IcoslD mice was possibly too small to be
pathogenically relevant, but this needed to be further investi-
gated. To assess the roles of Ab, we first measured serum immu-
noglobulin isotype concentrations. Immunoglobulin G1 (IgG1)
was reduced in both Itgax-IcoslD and Cd19-IcoslD mice (Fig-
ure 4A). In addition, we observed decreases for IgG2a and
IgG2b in Itgax-IcoslD mice. This demonstrates that ICOSL on
CD11c+ and B cells has non-redundant functions in the produc-
tion of class-switched Abs. Because auto-Abs in the MRL.Faslpr
strain are predominantly secreted by short-lived plasmablasts in
the spleen (Shlomchik, 2008), we enumerated splenic k-light
chain Ab-forming cells by ELISpot assay. Surprisingly, deletion
of Icosl inCD11c+orBcellsdidnotdiminishk-light chainAb-form-
ing cell numbers (Figure 4B).We thenmeasured anti-nucleosome
IgG1, IgG2a, and IgM serum concentrations. Anti-nucleosome
IgG2a was decreased in Itgax-IcoslD mice, as were anti-nucleo-
some IgG1 and IgM in Cd19-IcoslD mice (Figure 4C), but these
effects were modest. The number of anti-IgG1 and anti-IgG2a
rheumatoid factor producing cells was unaffected by the loss of
CD11c+ and B cells (Figure 4D). Overall, the contributions of
ICOSL on CD11c+ and B cells to auto-Ab production were small.
Importantly, if a loss of auto-Abswould have been responsible for
the dramatically reduced IN and interstitial pneumonia in Itgax-
IcoslD mice, we would have expected that deletion of Icosl in
CD11c+ cells would interfere more strongly with auto-Ab produc-
tion than Icosl ablation in B cells, which had no detectable
effect on tissue inflammation. This was, however, not the
case. These data, arguing against the notion that ICOS-driven
organdisease ismechanistically linked toauto-Abs, arecommen-
suratewith the presence of nephritis inMRL.Faslprmice harboring
B cells genetically rendered unable to secrete Ab (Chan et al.,
1999).
Figure 4. Auto-Ab Formation Is Largely Unimpaired in Mice Deficient for ICOSL on B Cells or CD11c+ Cells
(A) Serum Ig isotype concentrations of control (n = 20) and Itgax-IcoslD (n = 24) mice, or control (n = 21) and Cd19-IcoslD (n = 23) mice.
(B) Number of k light chain Ab-forming cells per spleen determined by ELISpot assay.
(C) Serum concentrations of anti-nucleosome IgG1, IgG2a, and IgGM.
(D) Number of anti-IgG1 and anti-IgG2a rheumatoid factor secreting cells per spleen determined by ELISpot assay.
In scatter plots, each dot represents an individual mouse and horizontal lines represent the median. Data in bar graphs are represented as mean ± SEM.
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Figure 5. Inflamed Kidneys in Lupus Harbor Tefh-like Cells that Strongly Depend on ICOS Stimulation by CD11c+ Cells
(A) Histograms (upper row) for ICOSL expression of cDCs in spleens and several CD11c+MHCII+ subsets in kidneys from control MRL.Faslpr (Icoslfl/fl, n = 4) Itgax-
IcoslD (n = 4) and Icosl/ (n = 2) mice. The gating strategy for each subset is indicated in the contour plots (lower row). Values indicate MFI minus background
staining (MFI of Icosl/).
(B) Numbers of CD4+ and CD8+ T cells per kidney of control (n = 9) and Itgax-IcoslD (n = 4) mice.
(C) Representative flow cytometry plot of PSGL-1lo and PSGL-1hi CD4+ T cells in kidneys from a 16-week-old WT MRL.Faslpr mouse.
(D) Representative histogram (left) for Bcl6 expression of renal PSGL-1lo and PSGL-1hi CD4+ T cells as gated in (C). The bar graph (right) presents data from five
animals.
(E) Flow cytometry plots show intracellular IL-21 and IFN-g staining of gated PSGL-1lo and PSGL-1hi CD4+ T cells in PMA-ionomycin stimulated kidney cell
suspensions from WT MRL.Faslpr mice. Values indicate percentage of the respective cell type (mean).
(F) Numbers of PSGL-1lo and PSGL-1hi CD4+ T cells per kidney (left) and percentage of PSGL-1lo and PSGL-1hi cells among CD4+ T cells in kidneys (right) of
control (nR 9) and Itgax-IcoslD (nR 4) mice.
(G) Mean fluorescence intensity (MFI) for Bcl6 of PSGL-1lo CD4+ T cells in kidneys from control (n = 6) and Itgax-IcoslD (n = 6) mice.
(H) IL-21 and IFN-g staining characteristics of gated PSGL-1lo CD4+ T cells in PMA-ionomycin stimulated kidney cell suspensions in control (n = 17) and Itgax-
IcoslD (n = 17) mice.
(legend continued on next page)
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Kidneys in Lupus Harbor Tefh-like Cells that Strongly
Depend on ICOS Stimulation by CD11c+ Cells
So far we had only examined the consequences of ICOS signals
on immune cells in lymphoid tissue. We hypothesized that
CD11c+ cells might sustain inflammation of target organs locally
via ICOS stimulation. Notably, CD11c+ cells are abundantly pre-
sent in inflamed kidneys (Teichmann et al., 2010) where B cells in
contrast are scarce. To investigate this, we compared ICOSL
expression on CD11c+ cells in kidneys and spleen. Dipeptidyl
peptidase-4 (DPP-4) was recently found to be more highly ex-
pressed by cDCs than by macrophages, thus facilitating the
distinction of these closely related cell types (Miller et al.,
2012). On the basis of DPP-4 expression and traditional myeloid
cell markers, we distinguished three CD11c+MHCII+ populations
in the kidneys: CD11chiMHCII+DPP-4+CD103+ cells that are
considered cDCs, CD11chiMHCII+DPP-4+CD103 cells that
likely consist of CD103 cDCs and monocyte-derived DCs,
and a CD11cintMHCII+DPP-4 subset that probably includes
macrophages (Figure 5A). Remarkably, all three renal CD11c+
subsets expressed much higher amounts of ICOSL than splenic
cDCs in MRL.Faslpr mice (Figure 5A). ICOSL was also strongly
expressed by CD11c+ cells in the lungs and skin (Figure S3A).
This expression pattern suggests that ICOS-ICOSL interactions
might be of particular importance for immune reactions in pe-
ripheral organs. Deletion of Icosl was effective in all examined
CD11c+ cell types in Itgax-IcoslD mice (Figure 5A and S3A).
ICOSL-deficiency in CD11c+ cells reduced the number of kid-
ney infiltrating CD4+ and CD8+ T cells by 38.0% and 50.2%,
respectively (Figure 5B), consistent with the robust decrease in
relative infiltrate size (Figures 1C and 1F). We detected a
PSGL-1lo subset of CD4+ T cells in kidneys from agedMRL.Faslpr
mice (Figure 5C). This subset expressed Bcl6 and was enriched
in IL-21 and IFN-g producers, thus sharing key features with
splenic Tefh cells (Figures 5D and 5E). These cells (called Tefh-
like hereafter) resemble a Bcl6+IL-21+ CD4+ T cell population
that infiltrates the pancreas and salivary glands in NOD mice, a
model of type I diabetes (McGuire et al., 2011). Both Tefh-like
and PSGL-1hi CD4+ T cells were diminished in kidneys from
Itgax-IcoslD compared to control mice (58.4% and 35.6%,
respectively) (Figure 5F, left). This contrasted with the selective
decrease in Tefh cells in spleens. The greater relative reduction
in Tefh-like cells, however, suggested that they are more depen-
dent on ICOS stimulation by CD11c+ cells than PSGL-1hi cells
and shifted the overall composition of the renal CD4+ T cell
pool toward less Tefh-like cells in Itgax-IcoslD mice (Figure 5F,
right). Icosl deletion in CD11c+ cells neither impaired Bcl6
expression (Figure 5G) nor the ability to produce IL-21 and
IFN-g (Figure 5H) by renal Tefh-like cells. This supports the
notion that ICOS triggering by CD11c+ cells is not required for
the genetic programming of renal Tefh-like cells. As expected,
CD8+ T cells in kidneys from MRL.Faslpr mice largely displayed
a Teff or Tem phenotype (Figure S3B). The function of renal
CD8+ T cells was unimpaired by the deletion of Icosl in CD11c+
cells based on granzyme B content and IFN-g production after
restimulation (Figure 5I).
We asked on which cell types in inflamed kidneys the secreted
IL-21 might act. To identify IL-21-responsive cell types, we stim-
ulated kidney single-cell suspension with rIL-21 and quantified
p-STAT3 by flow cytometry. Almost all CD4+ T cells, CD8+
T cells, and B cells were sensitive to IL-21 (Figure 5J). In addition,
p-STAT3 was increased in a subset of CD11c+MHCII+ cells.
Thus, IL-21 is broadly active on nephritic cell infiltrates.
Taken together, CD11c+ cells in inflamed kidneys expressed
high amounts of ICOSL. Deficiency for ICOSL in CD11c+ cells
reduced the number of all kidney infiltrating T cell subsets in
lupus with a disproportionately high decline in a novel population
of Tefh-like cells among CD4+ T cells.
ICOS Engagement by CD11c+ Cells Rescues Tfh Cell
Types and Effector CD8+ T Cells from Apoptosis
We sought to elucidate how the lack of ICOSL on CD11c+ cells
reduces the abundance of discrete T cell subsets in spleens
and kidneys. ICOS signals activate the PI3K-Akt pathway, which
promotes proliferation and survival. First, we evaluated prolifer-
ative activity by staining for Ki-67 Ag, which is preferentially ex-
pressed during late G1, S, G2, and M phase of the cell cycle,
by flow cytometry. Splenic Tefh cells and renal Tefh-like cells
were dividing less than their PSGL-1hi counterparts (Figures 6A
and 6B). ICOSL-deficiency in CD11c+ cells, however, did not
inhibit proliferation of either cell type. Of note, in Itgax-DTA
mice, which lack cDCs and CD11chi macrophages, fewer Tefh
cells were cycling than in controls (Figure S4A). Deletion of Icosl
in CD11c+ cells did not impede proliferation of splenic CD8+ Teff
and Tem cells (Figure 6A) or renal CD8+ T cells (Figure 6B).
Next, we tested whether Tefh, CD8+ Teff, and CD8+ Tem cells
in spleen undergo apoptosis at an increased rate in the absence
of ICOSL on CD11c+ cells. We used the FITC-labeled pan-cas-
pase inhibitor VAD-FMK and scatter characteristics to identify
apoptotic cells in spleens. Tefh cells were more often apoptotic
than PSGL-1hi CD4+ T cells (Figure 6C). ICOSL-deficiency in
CD11c+ cells led to a considerable increase in apoptosis among
Tefh cells, whereas there was no effect on PSGL-1hi CD4+ T cells
(Figures 6C and 6E). Further, survival of splenic CD8+ Teff and
Tem cells was impaired in Itgax-IcoslD mice compared to con-
trols (Figure 6C).
We also investigated apoptosis in kidney. Because caspase
activation is an early event during apoptosis, FITC-VAD-FMK
might label cells that became apoptotic either in vivo or during
kidney processing. To circumvent this issue, we used increased
cell membrane permeability, which is only observed at late
stages of apoptosis, as a measure for apoptosis in kidney sin-
gle-cell suspensions. Similar to the findings in spleens, Tefh-
like cells in kidneys were much more frequently apoptotic than
PSGL-1hi CD4+ T cells (Figure 6D). Critically, in Itgax-IcoslD
(I) Percentage of gated CD8+ T cells in kidney cell suspensions staining for granzyme B (left) or IFN-g (right, after restimulation with PMA-ionomycin) of control and
(nR 6) and Itgax-IcoslD (nR 6) mice.
(J) Histograms show p-STAT3 staining of gated CD4+ T cells, CD8+ T cells, CD11c+MHCII+ cells and B cells in kidney single-cell suspensions fromWTMRL.Faslpr
mice (n = 4). Kidney cells were treated with rIL-21 or left untreated for 30 min and then stained for p-STAT3. To determine background staining, we dephos-
phorylated a set of untreated samples with l protein phosphatase.
Data in bar graphs are represented as mean ± SEM. See also Figure S3.
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Figure 6. ICOS Engagement by CD11c+ Cells Rescues Tfh Cell Family Members and Effector CD8+ T Cells from Apoptosis in Lymphoid and
Peripheral Tissues
(A) Percentage of PSGL1hi CD4+ T cells and Tefh cells (left), or Teff and Tem CD8+ T cells (right) expressing the proliferation marker Ki67 in spleens from control
(black) and Itgax-IcoslD (white) mice.
(legend continued on next page)
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mice, the percentage of Tefh-like cells that underwent apoptosis
was higher than in controls (Figures 6D and 6F). Surprisingly,
ICOSL-deficiency in CD11c+ cells did not detectably affect sur-
vival of renal PSGL-1hi CD4+ T cells despite reducing their num-
ber. Similar to the situation for Tefh-like cells, more CD8+ T cells
in kidneys from Itgax-IcoslDmice were apoptotic than in controls
(Figure 6D). To confirm our results from kidney single-cell sus-
pensions, we detected apoptotic cells in situ on tissue sections
by TUNEL assay. The loss of ICOS stimulation by CD11c+ cells
led to an 8.8-fold increase in TUNEL+ cells per mm2 renal infil-
trate (Figures 6G and 6H).
It remained unclear whether improved T cell survival repre-
sented a primary effect of ICOS triggering by CD11c+ cells or a
secondary effect for example due to the release of cytokines
induced by ICOS signaling. In the latter case stimulation of a
cell via ICOS would also affect its neighboring cells. To distin-
guish these two possibilities, we generated chimeric mice in
which 50% of T cells originate from Icos/ and 50% from
Icos+/+ bone marrow. In these chimeras Icos/ Tefh-like cells,
PSGL-1hi CD4+ T cells, and CD8+ T cells less efficiently accumu-
lated in inflamed kidneys than their Icos+/+ counterparts (Fig-
ure S4B). Icos/ Tefh-like cells were underrepresented to the
greatest extent. These data were consistent with the notion of
a cell-intrinsic effect of ICOS ligation on T cell survival.
Taken together, the loss of cells belonging to the Tfh cell
family and effector CD8+ T cells in both spleens and kidneys of
Itgax-IcoslD mice resulted from impaired survival rather than
proliferation.
Lack of ICOS Stimulation by CD11c+ Cells Dampens
Endogenous Akt Activity in Renal T Cells
We recently described a phospho-flow technique that permits
direct ex vivo determination of the spontaneous endogenous
phosphorylation state of proteins (Khalil et al., 2012). We used
this method to find out whether deletion of Icosl in CD11c+ cells
might curtail Akt signaling, thus reducing survival of Tefh-like cells
and CD8+ T cells in inflamed kidneys. Activation of Akt requires
phosphorylation of threonine 308 (Thr308) and serine 473
(Ser473). Both phosphorylation events are dependent on PI3K.
Once activated, Akt stimulates the rapamycin-sensitive mTOR
complex-1 (TORC1) and subsequently S6K, which phosphory-
lates the ribosomal protein S6. Because p-S6 (Ser235/236) is
well-detected by phospho-flow it is a sensitive downstream
readout for Akt activity. Tefh-like cells in kidneys from aged
Itgax-IcoslDmice demonstrated reduced amounts of basal p-Akt
(Thr308), p-Akt (Ser473) and p-S6 (Ser235/236) compared to
those from controls (Figures 7A and 7B). We also observed
decreased amounts of p-Akt (Thr308) and p-S6 (Ser235/236) in
renal PSGL-1hi CD4+ T cells (Figure 7C). In addition there was
less S6 phosphorylation in CD8+ T cells (Figure 7D). Our data indi-
cate that in the absence of ICOSL on CD11c+ cells Akt activity is
reduced in all renal T cell subsets. This is consistent with the
finding that all T cell types were diminished in kidneys from
Itgax-IcoslD mice. It is important to acknowledge that other
PI3K-independent pathways downstream of ICOS exist but their
role in apoptosis is unclear. We conclude that in lupus nephritis
ICOSL-deficiency in CD11c+ cells is not compensated for by
ICOSL on other cell types or Akt activation by receptors other
than ICOS.
DISCUSSION
ICOS engagement drives the development of systemic autoim-
munity, which has been attributed to its key function in Tfh differ-
entiation and thus auto-Ab formation (Vinuesa et al., 2005). Here
we demonstrate that multi-organ inflammation in lupus critically
relies on ICOS stimulation by CD11c+ cells, which comprise DCs
and CD11c+ macrophages. In contrast, tissue infiltration was in-
dependent of ICOSL on B cells. Surprisingly, promotion of lupus
via ICOSL on CD11c+ cells was largely unrelated to the produc-
tion of auto-Abs. Rather, reduced T cell accrual in kidneys, ama-
jor target organ in lupus, of Itgax-IcoslD mice was caused by
impaired survival of various tissue-infiltrating T cell subsets.
Notably, these included a population of renal IL-21-secreting
Bcl6+ Th cells that likely interacts with T, B, and myeloid cells.
Increased apoptosis correlated with reduced endogenous activ-
ity of the PI3K-Akt cascade in renal T cells. CD11c+ Ag-present-
ing cell types in kidneys expressed high amounts of ICOSL,
suggesting that these cells locally induced essential PI3K-medi-
ated pro-survival signals in organ-infiltrating T cells via ICOS trig-
gering, thus actively maintaining peripheral inflammation.
Conflicting results have been published regarding the impact
of global ICOS deficiency on organ pathology in lupus (Odegard
et al., 2009; Zeller et al., 2006). Our study agrees with Odegard
et al. in demonstrating that ICOS is a critical determinant of
tissue inflammation and identifies CD11c+ cells as the main
(B) Percentage of PSGL1hi CD4+ T cells and Tefh-like cells (left), or CD8+ T cells (right) expressing the proliferaton marker Ki67 in kidneys from control (black) and
Itgax-IcoslD (white) mice.
(C) Percentage apoptotic cells (FSCloFITC-VAD-FMK+) among PSGL1hi CD4+ T cells and Tefh cells (left), or Tem and Teff CD8+ T cells (right) in spleens from
control (black) and Itgax-IcoslD (white) mice.
(D) Percentage apoptotic cells (FSCloYO-PRO1+PIlo) among PSGL1hi CD4+ T cells and Tefh-like cells (left), or CD8+ T cells (right) in kidneys from control (black)
and Itgax-IcoslD (white) mice.
(E) Flow cytometry plots show gating of apoptotic Tefh cells in spleens of control and Itgax-IcoslDmice. Numbers indicate percentage of Tefh cells. Results are
summarized in (C, left).
(F) Flow cytometry plots show gating of apoptotic Tefh-like cells in kidneys of control and Itgax-IcoslD mice. Numbers indicate percentage of Tefh-like cells.
Results are summarized in (D, left).
(G) Number of TUNEL+ cells per mm2 interstitial infiltrate in kidney sections of control (black) and Itgax-IcoslD (white) mice. One mid-sagittal longitudinal kidney
section was analyzed per mouse. All TUNEL+ cells on the entire section were counted and the total infiltrate area size was measured with ImageJ.
(H) Representative images of kidney sections stained by TUNEL assay, and with anti-CD4 and anti-CD8 of a control and an Itgax-IcoslD mouse (scale bar
represents 100 mm). The upper images show the area marked with pink dashed rectangles in the lower images at higher magnification. Infiltrates are encircled
with a yellow line in the lower images. Note that tubuloepithelial cells are strongly autofluorescent.
In scatter plots each dot represents an individual mouse and horizontal lines represent the median. See also Figure S4.
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drivers of ICOS-dependent organ disease. Indeed, the degree to
which proteinuria and IN was reduced in Itgax-IcoslD mice was
comparable to that previously described in globally ICOS-defi-
cient MRL.Faslpr mice (Odegard et al., 2009). Considering the
wide hematopoietic and parenchymal expression of ICOSL,
the strikingly selective importance of ICOSL on CD11c+ cells
was unexpected.
A plausible explanation for diminished organ disease in Itgax-
IcoslDmicewas that the lack of ICOS stimulation by CD11c+ cells
might have constrained auto-Ab production. However, several
lines of evidence indicate that this was not the case. First, the
impact of CD11c+ cell-specific Icosl deficiency on the anti-self-
humoral response was minor. Second, tissue inflammation in
Cd19-IcoslDmice was unabated despite effects on auto-Ab pro-
duction comparable to those seen Itgax-IcoslD mice. Third, we
have previously shown that the development of IN in MRL.Faslpr
mice does not require soluble immunoglobulin (Chan et al., 1999).
Thus, ICOS signals likely drive autoimmune pathology mainly
through mechanisms that do not depend on auto-Abs.
Consistent with a limited role for auto-Abs in ICOS-driven
inflammation in lupus, the Tefh cell differentiation program in
Itgax-IcoslD and Cd19-IcoslD mice was not disrupted. Deletion
of Icosl in CD11c+ or B cells of lupus-prone mice neither inter-
fered with expression of the Tfh master transcription factor
Bcl6 nor with production of the Tfh signature cytokine IL-21 by
Th cells. This contrasts with the established model for Tfh differ-
entiation in viral infection, in which sequential ICOS engagement
by DCs and B cells is required to institute the Tfh phenotype
(Choi et al., 2011). Notably, in Itgax-DTA and Jh MRL.Faslpr
mice that completely lack CD11c+ and B cells, respectively,
Bcl6 and IL-21 expression were reduced. Thus, the Tefh cell dif-
ferentiation program in lupus depends on CD11c+ and B cells,
but not ICOS triggering by either cell type. A recent report
showed in an ovalbumin immunization model that ICOSL display
by B cells is dispensable for Tfh polarization when Ag is abun-
dant (the loss of ICOSL on DCs was not investigated) (Weinstein
et al., 2014). Ubiquity of self-Ag is a characteristic feature of
lupus. We thus hypothesize that the lack of effect on Tefh differ-
entiation in lupus-prone mice deficient for Icosl in CD11c+ or B
cells results from broad Ag availability rather than from funda-
mental differences between Tefh in autoimmunity and Tfh cells
in infection.
Inflamed kidneys in lupus-prone mice harbored Th cells that
downregulated PSGL-1, expressed Bcl6, and secreted IL-21,
thereby resembling Tefh cells. A recent report demonstrated
that kidney samples from SLE patients contain ICOS+ Th cells
that partly interact with B cells (Liarski et al., 2014). Whether
these interactions lead to local plasmablast differentiation was
not addressed. Of note, b-islet destruction in the NOD mouse
model of type I diabetes depends on a subset of pancreas
Figure 7. Lack of ICOS Stimulation by CD11c+ Cells Dampens Endogenous Akt Activity in Renal T Cells
(A) Spontaneous signaling in renal Tefh-like cells. Histograms display representative results for p-Akt (Thr308), p-Akt (Ser473), and p-S6 (Ser235/236) staining of
gated Tefh-like cells in instantly fixed kidneys from a control and an Itgax-IcoslDmouse. Each histogram shows an overlay of l protein phosphatase-treated (gray
shaded) and untreated (colored) cells.
(B) Fold change of p-Akt (Thr308), p-Akt (Ser473), and p-S6 (Ser235/236) mean fluorescence intensity (MFI) of Tefh-like cells in instantly fixed kidneys of
Itgax-IcoslD mice (n = 15, white bars) relative to those of controls (n = 11, black bars). Individual fold-change values were calculated as DMFIi ( = MFIi, untreated –
MFIi, lPP) divided by the average of DMFIi values obtained from controls. Data are represented as mean ± SEM.
(C) As in (B) but gated on PSGL1hi CD4+ T cells.
(D) As in (B) but gated on CD8+ T cells.
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infiltrating CCR9+Bcl6+IL-21+ Th cells. Despite their relatedness
to Tfh cells, this subset primarily provides IL-21 to CD8+ T cells,
which facilitates CD8+ T cell expansion and survival (McGuire
et al., 2011). Further, IL-21 in NOD-NP mice is required for
pancreatic cDCs to acquire chemokine receptor 7, which
enables migration to the draining lymph node and priming of
self-reactive T cells (Van Belle et al., 2012). Because of these
observations we sought to identify the cell types residing in kid-
ney infiltrates of lupus mice on which IL-21 secreted by local
Tefh-like cells might impact. Virtually all CD4+ T cells, CD8+
T cells, B cells, and a subset of CD11c+ Ag-presenting cells
were responsive to IL-21. Although it was not feasible to more
definitively establish the function of IL-21 released by renal
Tefh-like cells, given that no tools exist to manipulate discrete
cell types only in specific locations, our experiments indicate
that Tefh-like cell-derived IL-21 has a wide range of targets in in-
flamed kidneys and thus might play a pivotal role.
Our study directly demonstrates that ICOSL display by
CD11c+ cells has non-redundant functions in preventing
apoptosis of Tfh cell family members and effector CD8+ T cells
in lymphoid tissue and, most importantly, in inflammatory organ
infiltrates. Icosl deletion in CD11c+ cells was linked to con-
strained spontaneous activity of the pro-survival PI3K-Akt
cascade in kidney infiltrating T cells. Consequently, other
possible stimuli of Akt in T cells, such as Ag-MHC complexes,
CD80, CD86, CD40L, cytokines, and chemokines, most of which
are probably abundantly available to T cells in systemic autoim-
munity, cannot compensate for the loss of ICOSL expressed by
CD11c+ cells. Given that PI3K activity is thought to collapse
within minutes when the triggering stimulus is withdrawn (Huppa
et al., 2003), it is likely that sustained PI3K-Akt signaling in renal
T cells reflects local ICOS stimulation. Importantly, this notion is
supported by our experiments revealing that ICOSL expression
on MHCII+CD11c+ cell subsets in inflamed kidneys is consider-
ably higher than on cDCs in lymphoid tissue. It is also noteworthy
that MHCII+CD11c+ cells are present at high density in kidneys
from aged MRL.Faslpr mice (10% of CD45+ cells). B cells are
rare in this location and Cd19-IcoslD mice showed no reduction
in nephritis. Interestingly, selective deficiency for MyD88 in
CD11c+ cells does not mitigate nephritis in lupus prone mice
(Teichmann et al., 2013). This suggests that the ability of
CD11c+ cells to maintain kidney infiltrating T cells is not imparted
by Toll-like receptor or IL-1R-IL-18R signals but likely depends
on signals induced by the T cells they interact with.
In conclusion, we define CD11c+ Ag-presenting cells to be the
main drivers of ICOS-dependent lupus pathology and establish
that ICOS triggering by this population perpetuates target
organ inflammation by protecting organ infiltrating T cells from
apoptosis via induction of PI3K-Akt signaling rather than by
biasing T cell differentiation and propelling auto-Ab production.
This mechanism potentially applies to many other autoimmune
and alloimmune conditions that rely on ICOS, for example type
I diabetes (Hawiger et al., 2008), rheumatoid arthritis (Iwai et al.,
2002), polymyositis (Katsumata et al., 2007), and chronic allograft
rejection (Ozkaynak et al., 2001). Interestingly, in each of these
diseases B cells are implicated as the upstream APCs for global
T cell activation (Takemura et al., 2001; Wong et al., 2004; Zeng
et al., 2014). ICOSblockademight serve as an effective approach
to turn off chronic, destructive organ inflammation regardless of
the nature of the disease initiating processes by truncating the
late effector stage of the pathological T cell response.
EXPERIMENTAL PROCEDURES
Mice
Icoslfl/+ C57BL/6 mice were as described (Nurieva et al., 2003) and Itgax-Cre
BAC transgenic C57BL/6 mice (Caton et al., 2007) were kindly provided
by Boris Reizis. Cd19-Cre C57BL/6, Rosa26-eGFP-DTA C57BL/6 and Jh
(Igh-Jtm1Dhu) Balb/c mice were purchased from the Jackson Laboratory or
Taconic. All animals were backcrossed to MRL-MpJ-Faslpr/J mice (Jackson
Laboratory) for at least 10 generations. Itgax-IcoslD and Cd19-IcoslD mice
were generated by interbreeding Icoslfl/fl with Itgax-Cre Icoslfl/fl or CD19-Cre
Icoslfl/fl MRL.Faslpr mice, respectively. Littermates without a Cre allele were
used as controls. Mice were analyzed at 16–18 weeks of age unless stated
otherwise. All animals were maintained under specific pathogen-free (SPF)
conditions and handled according to protocols approved by the Yale Institu-
tional Animal Care and Use Committee.
Preparation of Kidney Single-Cell Suspensions
After perfusion of mice with DPBS, kidneys were removed, minced, and di-
gested in HBSS containing 100 Mandl U/ml collagenase D (Roche) and 50 Ku-
nitz U/ml DNase I (Sigma-Aldrich). Tissue pieces were then pressed through a
70 mm strainer to obtain single-cell suspensions. Cells were enriched in leuko-
cytes using an 80/20 percoll gradient.
Standard Flow Cytometry
Surface staining was performed in ice-cold PBS with 3% calf serum in the
presence of FcR blocking Ab 2.4G2. Ab clones used for FACS can be found
in the Supplemental Information. Intracellular staining was performed using
the BD Cytofix/Cytoperm and Perm/Wash buffers or, for intracellular Bcl6,
Ki67 and FoxP3 staining, the eBioscience FoxP3 staining buffer set. For intra-
cellular IL-21 and IFN-g staining, 53 106 splenocytes were cultured for 5 hr at
37C in 24-well plates in 2ml culturemedium containing ionomycin (750 ng/ml)
and PMA (20 ng/ml). For the last 4 hr brefeldin A (10 mg/ml) was added to the
cultures. IL-21was detectedwith a recombinant mouse IL-21R subunit/human
IgG1 Fc chimera (R&D systems) with goat anti-human Fcg conjugated to PE
(Jackson ImmunoResearch). Cells were analyzed on a LSRII instrument
(BD). For purification of populations, cells were sorted on a FACSAria II (BD).
Phospho-Flow
For identification of IL-21 responsive cell types in kidneys, freshly prepared
kidney single-cell suspensions were incubated with rIL-21 (20 ng/ml, R&D sys-
tems) for 30 min or left untreated. Cells were fixed with 1% paraformaldehyde,
permeabilized with 90% methanol and washed. Aliquots of untreated cells
were dephosphorylated with l protein phosphatase (NEB BioLabs). All sam-
ples were then stained with p-STAT3 (Tyr705) antibody (Cell Signaling). To
determine the endogenous phosphorylation state of Akt and S6 in renal
T cell populations, we directly disrupted kidneys in RPMI containing 1% para-
formaldehyde. Fixed cells were permeabilized with 90% methanol and
washed, and aliquots of all samples were incubated with l protein phospha-
tase. Cells were stained with p-Akt (Ser308), p-Akt (Thr473), or p-S6
(Ser235/236) antibody (Cell Signaling).
Apoptosis
For flow-cytometric detection of apoptotic cells in spleens, freshly prepared
cell suspensions were stained for active caspases with FITC-VAD-FMK (SM
Biochemicals). To identify apoptotic cells by FACS in kidneys, we monitored
cell-membrane permeability by staining with YO-PRO1 in combination with
propidium iodide. Apoptotic cells in kidney tissue sections were visualized
by TUNELmethod using the ApoAlert DNA Fragmentation Assay Kit (Clontech)
as per the manufacturer’s instructions.
ELISpots, Luminex, and ELISA
ELISpot assays to enumerate Ab-forming cells that produce k light chain
Abs, anti-IgG1, or anti-IgG2a rheumatoid factor in spleens, Luminex assays
to measure serum Ig isotype concentrations, and ELISAs to determine serum
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anti-nucleosome IgG, IgG1, and IgG2a concentrations were all performed as
reported (Teichmann et al., 2013).
Evaluation of Clinical Disease
Nephritis, proteinuria, and dermatitis were scored as previously described
(Teichmann et al., 2010). For pulmonary disease, formalin-fixed, and
paraffin-embedded sections of the left lung, stained with H&E, were scored
for cellular interstitial pneumonia from 0 to 6 (0, none; 6, severe) in a blinded
fashion. The percentage area of renal and pulmonary interstitial infiltrates
was determined with ImageJ software.
Statistical Analysis
Statistics were calculated by two-tailed Mann-Whitney U test with p values
indicated throughout as *p < 0.05, **p < 0.01, ***p < 0.001.
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